| Bioactivity | LY-195448 hydrochloride is a phenethanolamine that exhibits anti-tumour activity across various murine tumour models. LY-195448 hydrochloride acts by blocking cells at metaphase. LY-195448 hydrochloride has demonstrated a lack of "standard" side effects commonly associated with cancer treatments, such as myelosuppression and gastrointestinal toxicity. LY-195448 hydrochloride was evaluated in a phase I trial, where it showed only mild and reversible side effects like hypotension, tachycardia, and tremor. |
| CAS | 111112-18-6 |
| Formula | C20H27ClN2O2 |
| Molar Mass | 362.89 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Phase I clinical and pharmacokinetic study of LY 195448 |
LY-195448 hydrochloride
CAS: 111112-18-6 F: C20H27ClN2O2 W: 362.89
LY-195448 hydrochloride is a phenethanolamine that exhibits anti-tumour activity across various murine tumour models. LY
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.